KUALA LUMPUR: Hong Seng Consolidated Bhd’s wholly-owned subsidiary, HS Bio Sdn Bhd (HS Bio) has entered into a share sale agreement to acquire a 51 per cent stake in the COVID-19 antibody test kit distributor RZAC Immunesafe Sdn Bhd for RM20 million.
In a statement today, Hong Seng said the total purchase consideration of RM20 million comprises a cash payment of RM2 million and the issuance of 37,800 new ordinary shares in HS Bio worth RM18 million.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!